"Flurbiprofen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
| Descriptor ID |
D005480
|
| MeSH Number(s) |
D02.241.081.751.161 D02.455.426.559.389.185.350
|
| Concept/Terms |
Flurbiprofen- Flurbiprofen
- Fluriproben
- 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic Acid
- Flubiprofen
|
Below are MeSH descriptors whose meaning is more general than "Flurbiprofen".
Below are MeSH descriptors whose meaning is more specific than "Flurbiprofen".
This graph shows the total number of publications written about "Flurbiprofen" by people in this website by year, and whether "Flurbiprofen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flurbiprofen" by people in Profiles.
-
Tan J, Li C, Wang Q, Li S, Chen S, Zhang J, Wang PC, Ren L, Liang XJ. A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity. Mol Pharm. 2018 04 02; 15(4):1724-1728.
-
Borgegard T, Jur?us A, Olsson F, Rosqvist S, Sabirsh A, Rotticci D, Paulsen K, Klintenberg R, Yan H, Waldman M, Stromberg K, Nord J, Johansson J, Regner A, Parpal S, Malinowsky D, Radesater AC, Li T, Singh R, Eriksson H, Lundkvist J. First and second generation ?-secretase modulators (GSMs) modulate amyloid-? (A?) peptide production through different mechanisms. J Biol Chem. 2012 Apr 06; 287(15):11810-9.
-
Zhao M, Destache CJ, Ohia SE, Opere CA. Role of prostanoid production and receptors in the regulation of retinal endogenous amino acid neurotransmitters by 8-isoprostaglandin E2, ex vivo. Neurochem Res. 2009 Dec; 34(12):2170-80.
-
Ohia SE, Zhan GL, Leday AM, Opere CA, Kulkarni KH, Harris LC, Roche VF. Ocular pharmacology of bicyclic hexahydroaporphines. Methods Find Exp Clin Pharmacol. 2005 Mar; 27(2):87-93.
-
LeDay AM, Kulkarni KH, Opere CA, Ohia SE. Arachidonic acid metabolites and peroxide-induced inhibition of [3H]D-aspartate release from bovine isolated retinae. Curr Eye Res. 2004 May; 28(5):367-72.
-
Graham J, Awe SO, LeDay AM, Rice JC, Ramos G, Harris LC, Opere CA, Ohia SE. Effect of inhibition of cyclooxygenase on pre- and postjunctional actions of peroxides in the iris-ciliary body. Neurochem Res. 2000 Apr; 25(4):519-25.
-
Zhan GL, Ohia SE, Camras CB, Ohia EO, Wang YL. Superior cervical ganglionectomy-induced lowering of intraocular pressure in rabbits: role of prostaglandins and neuropeptide Y. Gen Pharmacol. 1999 Feb; 32(2):189-94.
-
al-Zadjali KH, Imler MP, Ohia SE. Inhibitory effect of prostaglandins on dopamine release from the retina. Gen Pharmacol. 1994 Mar; 25(2):289-96.
-
al-Zadjali KH, Boyle FC, Ohia SE. Inhibition of prostaglandin synthetase alters uterine response to adrenoceptor agonists in pregnant and post-partum rats. Gen Pharmacol. 1991; 22(5):855-61.
-
Ohia SE, Boyle FC. Role of cyclic AMP in rat uterine inhibitory response to salbutamol during the natural oestrous cycle. Arch Int Pharmacodyn Ther. 1988 May-Jun; 293:245-56.